Furthermore, the HDAC inhibitor SAHA (marketed as Vorinostat or Zolinza) significantly prevented tumor cell proliferation by increasing expression of the cell cycle kinase p21WAF1 and decreasing expression of HDAC2 and 7 in ESS-1 cells [13]. This evidence concerns the gene HDAC9 and neoplasm.